Rice Hall James & Associates, LLC Evolus, Inc. Transaction History
Rice Hall James & Associates, LLC
- $1.66 Billion
- Q4 2024
A detailed history of Rice Hall James & Associates, LLC transactions in Evolus, Inc. stock. As of the latest transaction made, Rice Hall James & Associates, LLC holds 948,281 shares of EOLS stock, worth $13.2 Million. This represents 0.63% of its overall portfolio holdings.
Number of Shares
948,281
Previous 904,900
4.79%
Holding current value
$13.2 Million
Previous $14.7 Million
28.58%
% of portfolio
0.63%
Previous 0.87%
Shares
8 transactions
Others Institutions Holding EOLS
# of Institutions
166Shares Held
47.3MCall Options Held
130KPut Options Held
51K-
Perceptive Advisors LLC New York, NY5.36MShares$74.8 Million2.27% of portfolio
-
Tang Capital Management LLC San Diego, CA4.85MShares$67.7 Million6.69% of portfolio
-
Black Rock Inc. New York, NY4.01MShares$56 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.2MShares$44.6 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.82MShares$39.5 Million2.72% of portfolio
About Evolus, Inc.
- Ticker EOLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 56,094,800
- Market Cap $784M
- Description
- Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...